Cargando…
The paradigm of tumor shrinkage and rapid liver remnant hypertrophy for conversion of initially unresectable colorectal liver metastasis: a case report and literature review
BACKGROUND: For colorectal liver metastasis (CRLM) patients, hepatic resection is currently the sole cure offering the chance of long-term survival. Tumor shrinkage and planned liver remnant hypertrophy are the two key strategies for conversion of initially unresectable CRLM. First conducted in 2012...
Autores principales: | Xiao, Nan, Yu, Kailin, Yu, Shaojun, Wu, Jianjun, Wang, Jian, Shan, Siyang, Zheng, Shuchun, Wang, Liuhong, Wang, Jianwei, Peng, Shuyou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5543586/ https://www.ncbi.nlm.nih.gov/pubmed/28774330 http://dx.doi.org/10.1186/s12957-017-1212-6 |
Ejemplares similares
-
Current strategies to induce liver remnant hypertrophy before major liver resection
por: Del Basso, Celeste, et al.
Publicado: (2021) -
Portal vein embolization with absolute ethanol to induce hypertrophy of the future liver remnant
por: Santhakumar, Cositha, et al.
Publicado: (2022) -
Influence of cholestasis on portal vein embolization-induced hypertrophy of the future liver remnant
por: Chang, Xinwei, et al.
Publicado: (2023) -
Treatment effect of conversion therapy and its correlation with VEGF expression in unresectable rectal cancer with liver metastasis
por: Hou, Ge, et al.
Publicado: (2018) -
Predictive Factors for Hypertrophy of the Future Liver Remnant After Portal Vein Embolization: A Systematic Review
por: Soykan, E. A., et al.
Publicado: (2021)